Jennifer Jane Gile (Jennifer J Gile, Jennifer Gile)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Systemic Lupus Erythematosus

Drug Administration

Stem Cell Transplantation

Top Venues

JCO precision oncology

Blood cancer journal

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Allison M Bock, Jennifer Jane Gile, Melissa C Larson, Kittika Poonsombudlert, Reema K Tawfiq, Seth Maliske, Matthew John Maurer, Brian F Kabat, Jonas Paludo, David J Inwards, Sabarish Ayyappan, Brian K Link, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski, James R Cerhan, Umar Farooq, Yucai Wang
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study. Blood cancer journal 13 (1) (2023)
Jennifer Jane Gile, Patrick W McGarrah, Konstantinos Leventakos, Mohamad B Sonbol, Jason S Starr, Rachel A Eiring, Timothy J Hobday, Thorvardur R Halfdanarson
Efficacy of first-line checkpoint inhibitors in combination with chemotherapy in high-grade extrapulmonary metastatic neuroendocrine carcinomas. Journal of neuroendocrinology (2023)
Jennifer Jane Gile, Vanessa Wookey, Tyler J Zemla, Qian Shi, Zhaohui Jin, Steven R Alberts, Robert R McWilliams, Wen Wee Ma, Mitesh Borad, Tanios S Bekaii-Saab, Nguyen H Tran, Amit Mahipal
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma. Targeted oncology 17 (5) (2022)
Michael H Storandt, Jennifer Jane Gile, Mathias E Palmer, Tyler J Zemla, Daniel H Ahn, Tanios S Bekaii-Saab, Zhaohui Jin, Nguyen H Tran, Amit Mahipal
Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma. Cancers 14 (21) (2022)
Jennifer Jane Gile, Aminah Jatoi, Wen Wee Ma, Mitesh J Borad, Nguyen H Tran
Reply to A. Rizzo et al. JCO precision oncology 6 (2022)
Jennifer Jane Gile, Fang-Shu Ou, Amit Mahipal, Joseph J Larson, Kabir Mody, Zhaohui Jin, Joleen M Hubbard, Thorvardur R Halfdanarson, Steven R Alberts, Aminah Jatoi, Robert R McWilliams, Wen Wee Ma, Sumera Ilyas, Rory Smoot, Lewis Rowland Roberts, Gregory Gores, Mitesh J Borad, Tanios S Bekaii-Saab, Nguyen H Tran
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience. JCO precision oncology 5 (2021)
Jennifer Jane Gile, Camden L Lopez, Gordon J Ruan, Matthew A Hathcock, Jithma P Abeykoon, Joy R Heimgartner, Nikola A Baumann, M Molly McMahon, Ivana N Micallef, Patrick B Johnston, Jose C Villasboas Bisneto, Luis F Porrata, Jonas Paludo, Stephen M Ansell, William Joseph Hogan, Thomas E Witzig
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure. Blood cancer journal 11 (3) (2021)
Jennifer Jane Gile, Jaskanwal Deep Singh Sara, Michael R Mueller
Systemic lupus erythematosus multiorgan flare with quiescent serologic markers. BMJ case reports 14 (3) (2021)
Jennifer Jane Gile, Gordon Ruan, Jithma Abeykoon, M Molly McMahon, William R Macon, Thomas E Witzig
Hypomagnesemia is associated with an increased risk of early clinical failure in patients with Burkitt lymphoma. Leukemia & lymphoma 61 (9) (2020)